146 related articles for article (PubMed ID: 36290898)
1. Stereotactic Body Radiation Therapy for Lung and Liver Oligometastases from Breast Cancer: Toxicity Data of a Prospective Non-Randomized Phase II Trial.
Franceschini D; Comito T; Di Gallo A; Vernier V; Marzo MA; Di Cristina L; Marini B; Lo Faro L; Stefanini S; Spoto R; Dominici L; Franzese C; Scorsetti M
Curr Oncol; 2022 Oct; 29(10):7858-7867. PubMed ID: 36290898
[TBL] [Abstract][Full Text] [Related]
2. Definitive results of a prospective non-randomized phase 2 study on stereotactic body radiation therapy (sbrt) for medically inoperable lung and liver oligometastases from breast cancer.
Franceschini D; Franzese C; Comito T; Ilieva MB; Spoto R; Marzo AM; Dominici L; Massaro M; Bellu L; Badalamenti M; Mancosu P; Scorsetti M
Radiother Oncol; 2024 Jun; 195():110240. PubMed ID: 38522597
[TBL] [Abstract][Full Text] [Related]
3. Stereotactic body radiation therapy: A promising chance for oligometastatic breast cancer.
Scorsetti M; Franceschini D; De Rose F; Comito T; Villa E; Iftode C; Navarria P; D'Agostino GR; Masci G; Torrisi R; Testori A; Tinterri C; Santoro A
Breast; 2016 Apr; 26():11-7. PubMed ID: 27017237
[TBL] [Abstract][Full Text] [Related]
4. Radical radiation therapy for oligometastatic breast cancer: Results of a prospective phase II trial.
Trovo M; Furlan C; Polesel J; Fiorica F; Arcangeli S; Giaj-Levra N; Alongi F; Del Conte A; Militello L; Muraro E; Martorelli D; Spazzapan S; Berretta M
Radiother Oncol; 2018 Jan; 126(1):177-180. PubMed ID: 28943046
[TBL] [Abstract][Full Text] [Related]
5. A single-institution study of stereotactic body radiotherapy for patients with unresectable visceral pulmonary or hepatic oligometastases.
Fumagalli I; Bibault JE; Dewas S; Kramar A; Mirabel X; Prevost B; Lacornerie T; Jerraya H; Lartigau E
Radiat Oncol; 2012 Sep; 7():164. PubMed ID: 23014094
[TBL] [Abstract][Full Text] [Related]
6. [Stereotactic body radiation therapy for patients with lung and liver oligometastases from colorectal cancer: a phase Ⅱ trial].
Lei JQ; Liu WY; Tang Y; Tang Y; Li N; Ren H; Yihebali C; Sun YK; Zhang W; Bi XY; Zhao JJ; Fang H; Lu NN; Zhou AP; Wang SL; Song YW; Liu YP; Chen B; Qi SN; Cai JQ; Li YX; Jin J
Zhonghua Zhong Liu Za Zhi; 2022 Mar; 44(3):282-290. PubMed ID: 35316879
[No Abstract] [Full Text] [Related]
7. Efficacy of extracranial stereotactic body radiation therapy (SBRT) added to standard treatment in patients with solid tumors (breast, prostate and non-small cell lung cancer) with up to 3 bone-only metastases: study protocol for a randomised phase III trial (STEREO-OS).
Thureau S; Marchesi V; Vieillard MH; Perrier L; Lisbona A; Leheurteur M; Tredaniel J; Culine S; Dubray B; Bonnet N; Asselain B; Salleron J; Faivre JC
BMC Cancer; 2021 Feb; 21(1):117. PubMed ID: 33541288
[TBL] [Abstract][Full Text] [Related]
8. Stereotactic body radiotherapy in the management of oligometastatic and recurrent biliary tract cancer: single-institution analysis of outcome and toxicity.
Franzese C; Bonu ML; Comito T; Clerici E; Loi M; Navarria P; Franceschini D; Pressiani T; Rimassa L; Scorsetti M
J Cancer Res Clin Oncol; 2020 Sep; 146(9):2289-2297. PubMed ID: 32524292
[TBL] [Abstract][Full Text] [Related]
9. Interim analysis of a prospective phase I/II trial of SBRT for liver metastases.
Kavanagh BD; Schefter TE; Cardenes HR; Stieber VW; Raben D; Timmerman RD; McCarter MD; Burri S; Nedzi LA; Sawyer TE; Gaspar LE
Acta Oncol; 2006; 45(7):848-55. PubMed ID: 16982549
[TBL] [Abstract][Full Text] [Related]
10. Treatment outcomes of breast cancer liver metastasis treated with stereotactic body radiotherapy.
Onal C; Guler OC; Yildirim BA
Breast; 2018 Dec; 42():150-156. PubMed ID: 30296648
[TBL] [Abstract][Full Text] [Related]
11. Multi-institutional phase I/II trial of stereotactic body radiation therapy for liver metastases.
Rusthoven KE; Kavanagh BD; Cardenes H; Stieber VW; Burri SH; Feigenberg SJ; Chidel MA; Pugh TJ; Franklin W; Kane M; Gaspar LE; Schefter TE
J Clin Oncol; 2009 Apr; 27(10):1572-8. PubMed ID: 19255321
[TBL] [Abstract][Full Text] [Related]
12. Stereotactic Body Radiotherapy for Oligometastatic Prostate Cancer Detected via Prostate-specific Membrane Antigen Positron Emission Tomography.
Kneebone A; Hruby G; Ainsworth H; Byrne K; Brown C; Guo L; Guminski A; Eade T
Eur Urol Oncol; 2018 Dec; 1(6):531-537. PubMed ID: 31158100
[TBL] [Abstract][Full Text] [Related]
13. Stereotactic Body Radiotherapy in the Management of Oligometastatic Disease.
Ahmed KA; Torres-Roca JF
Cancer Control; 2016 Jan; 23(1):21-9. PubMed ID: 27009453
[TBL] [Abstract][Full Text] [Related]
14. Robotic stereotactic radiotherapy for liver oligometastases from colorectal cancer: a single-center experience.
Vernaleone M; Bonomo P; Di Cataldo V; Saieva C; Masi L; Desideri I; Greto D; Francolini G; Becherini C; Livi L
Radiol Med; 2019 Sep; 124(9):870-876. PubMed ID: 31104277
[TBL] [Abstract][Full Text] [Related]
15. Curative-intent radiotherapy in patients with oligometastatic lesions from colorectal cancer: A single-center study.
He X; Zhang P; Li Z; Bi F; Xu F; Wang X; Shen Y; Li Q; Qiu M
Medicine (Baltimore); 2018 Oct; 97(40):e12601. PubMed ID: 30290630
[TBL] [Abstract][Full Text] [Related]
16. Outcomes and toxicities of stereotactic body radiation therapy for non-spine bone oligometastases.
Owen D; Laack NN; Mayo CS; Garces YI; Park SS; Bauer HJ; Nelson K; Miller RW; Brown PD; Olivier KR
Pract Radiat Oncol; 2014; 4(2):e143-e149. PubMed ID: 24890360
[TBL] [Abstract][Full Text] [Related]
17. Phase II study of stereotactic body radiotherapy to primary tumor and metastatic locations in oligometastatic nonsmall-cell lung cancer patients.
Collen C; Christian N; Schallier D; Meysman M; Duchateau M; Storme G; De Ridder M
Ann Oncol; 2014 Oct; 25(10):1954-1959. PubMed ID: 25114022
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of stereotactic body radiotherapy (SBRT) in oligometastatic/persistent/recurrent ovarian cancer: a prospective, multicenter phase II study (MITO-RT3/RAD).
Macchia G; Jereczek-Fossa BA; Lazzari R; Cerrotta A; Deodato F; Ippolito E; Aristei C; Gambacorta MA; Scambia G; Valentini V; Ferrandina G
Int J Gynecol Cancer; 2022 Jul; 32(7):939-943. PubMed ID: 34155084
[TBL] [Abstract][Full Text] [Related]
19. A Contemporary Update on the Role of Stereotactic Body Radiation Therapy (SBRT) for Liver Metastases in the Evolving Landscape of Oligometastatic Disease Management.
Robin TP; Raben D; Schefter TE
Semin Radiat Oncol; 2018 Oct; 28(4):288-294. PubMed ID: 30309639
[TBL] [Abstract][Full Text] [Related]
20. Oligometastases treated with stereotactic body radiotherapy: long-term follow-up of prospective study.
Milano MT; Katz AW; Zhang H; Okunieff P
Int J Radiat Oncol Biol Phys; 2012 Jul; 83(3):878-86. PubMed ID: 22172903
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
